AzTrials
AzTrials

Cancer SurvivorshipNCT06844981

Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

A study testing Latin Dance in people with Cancer Survivorship and Sleep Disturbances, run by Rutgers, The State University of New Jersey at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objective is to assess the feasibility, acceptability and explore the impact of a culturally appropriate Latin Dance intervention vs. Usual Care on sleep quality for Hispanic cancer survivors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cancer Survivorship, Sleep Disturbances
What is being tested?
Latin Dance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
1 Apr 2026to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be 18 years of age or older
  • Self-identify as Hispanic and/or Latino(a)
  • Have a confirmed diagnosis of a solid tumor or hematologic malignancy
  • Must have completed primary cancer treatment 3+ months prior to enrollment (e.g., chemotherapy, surgery, and/or radiation therapy but may be on hormonal therapy and/or immunotherapy or other long-term therapies)
  • Have sleep disturbance (indicated by a response of 3 or more on the MD Anderson Symptom Inventory sleep question by using an 11-point scale anchored by 0 [no sleep disturbance] and 10 [worst possible sleep disturbance]
  • Be able to read and understand English and/or Spanish
  • Physically Inactive (<150 minutes of vigorous exercise/week within the past 3 months)

Who cannot join

  • Current regular Latin dancing practice within the past year (2-3 times a week over a period of two months that is not interrupted).
  • Inability to speak and read English or Spanish proficiently
  • Inability to understand informed consent
  • Medical conditions that can cause sleep impairment: sleep apnea, restless leg syndrome, shift work
  • Regular use of a walker or wheelchair
  • Healing or unhealed fractures
Show all 9Show fewer
  • Heart failure
  • Life expectancy <12 months
  • Unwilling to be randomized to study arms and/or commit to 8 weeks of classes and a follow-up assessment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Evelyn Arana, DrPH contact

908-642-0861

earana@CINJ.Rutgers.edu

Arlette Chavez, MD contact

732-715-4923

ac2758@CINJ.Rutgers.edu

United States1 site, 1 recruiting
  • Rutgers Cancer Institute

    New Brunswick, New Jersey, 08901

    Recruiting

Other trials in United States

About this study

Official title: Moviendo Las Caderas: Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

The primary objective is to assess the feasibility, acceptability and explore the impact of a culturally appropriate Latin Dance intervention vs. Usual Care on sleep quality for Hispanic cancer survivors.

Secondary objectives are to examine the preliminary efficacy of a culturally appropriate Latin Dance intervention on secondary cancer- and treatment-related side effects (e.g., Quality of Life, distress, insomnia, fatigue).

Read the detailed description

In this feasibility Randomized Control Trial (RCT) study, the investigators will assess the feasibility, acceptability, and explore the impact of a Latin dance intervention vs usual care on sleep quality among Hispanic survivors.

Study Aims:

Aim 1: Develop a culturally appropriate Latin dance intervention for Hispanic cancer survivors using a bidirectional community engagement approach. Using iterative qualitative feedback from Hispanic cancer survivors, the investigators will develop a Latin dance intervention for Hispanic cancer survivors.

Aim 2: Assess the feasibility and acceptability of a culturally appropriate Latin Dance intervention for Hispanic cancer survivors.

Aim 3: Provide preliminary evidence of the efficacy potential of a culturally appropriate Latin Dance intervention vs. usual care on subjective and objective sleep quality for Hispanic survivors.

Being tested
Latin Dance
Keywords
Cancer, Cancer Survivorship, Sleep Disturbances, Hispanic Cancer Survivors, Latin Dancing
Medical subject headings
Parasomnias, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Latin DanceBehavioural

    Also called intervention arm

    Latin Dance intervention

Study groups in NCT06844981
Study groupRoleWhat they receive
Usual care armNo interventionParticipants in the usual care arm will receive care as usual and will not participate in the Latin Dancing program.
Intervention armExperimentalParticipants in this arm will participate in the virtual Latin Dance group program that meets for 8 weeks, 2x each week, for 75 minute sessions.
Receives: Behavioral: Latin Dance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the Intervention

    Feasibility in this study will include recruitment, adherence, and retention rates.

    Measured: 8 weeks

  2. Treatment Perception Questionnaire (Acceptability of Intervention)

    Acceptability is defined as at least 80% of participants in the Latin Dance group agreeing or strongly agreeing that the intervention was acceptable via the Treatment Perceptions Questionnaire (TPQ). The TPQ consists of 10 statements about treatment satisfaction on a Likert-type scale from 0 (strongly disagree) to 4 (strongly agree). Average scores ≥ 3 indicated acceptable satisfaction.

    Measured: Post-intervention (at approximately 8 weeks)

  3. Pittsburgh Sleep Quality Index

    Changes in sleep quality will be assessed pre and post-intervention with the Pittsburgh Sleep Quality Index (PSQI). The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality.

    Measured: Baseline and post-intervention (approximately 8 weeks)

Secondary outcomes (17)
  1. Functional Outcomes for Cancer Therapy - General

    Quality of Life will be assessed via the Functional Outcomes for Cancer Therapy - General (FACT-G). This measure consists of 27 items designed to measure four domains of quality of life in cancer patients: physical, social, emotional, and functional well-being. Coefficients of reliability and validity are uniformly high. The physical, social, and functional domain scores range from 0-28 with higher scores indicating better quality of life. The emotional domain score ranges from 0 - 24 with higher scores indicating better quality of life. The FACT-G total score ranges from 0 - 108, with higher scores indicating better quality of life.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  2. Functional Assessment of Chronic Illness - Fatigue

    Fatigue will be assessed with the Functional Assessment of Chronic Illness - Fatigue (FACIT-F) Scale. Higher scores indicate less fatigue (score range=0-52).

    Measured: Baseline and post-intervention (approximately 8 weeks)

  3. Patient Health Questionnaire - 2 (PHQ-2)

    The PHQ-2 is a two-item screening questionnaire for depression that asks about the frequency of a depressed mood and loss of interest or pleasure in the last two weeks. Each of the two questions is scored from 0 to 3, based on frequency. The two scores are added together for a total score ranging from 0 to 6. A total score of 3 or higher indicates a positive screen for depression.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  4. Generalized Anxiety Disorder - 7 (GAD-7)

    The GAD-7 is used for screening and measuring the severity of generalized anxiety disorder (GAD). The total score indicates the severity of anxiety, from minimal (0-4) to severe (15 and above)

    Measured: Baseline and post-intervention (approximately 8 weeks)

  5. Insomnia Severity Index

    Insomnia will be assessed with the Insomnia Severity Index (ISI). A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  6. Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy

    Actigraphy will measure the number of minutes of actual sleep.

    Measured: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)

  7. Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy

    Actigraphy will measure total minutes of wake time after sleep onset.

    Measured: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)

  8. Objective Symptoms of Insomnia- Sleep Efficiency via Actigraphy

    Actigraphy will measure the percent of time actually slept compared to intended time sleeping.

    Measured: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)

  9. Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy

    Actigraphy will measure the minutes it takes for the participant to fall asleep.

    Measured: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)

  10. Charleson Comorbidity Index

    The Charleson Comorbidity Index consists of 19 items, each with an assigned weight from 1 to 6 according to the relative risk of dying within a year. In general, the absence of comorbidity is considered: 0-1 points; low comorbidity: 2 points; and high comorbidity: ≥3 points.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  11. Physical Activity Daily Diaries

    The physical activity daily diary is designed to gather information about participants' daily physical activity patterns.

    Measured: Physical activity daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.

  12. Sleep Daily Diaries

    The sleep diary is designed to gather information about participants' daily sleep patterns.

    Measured: Sleep daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.

  13. Self-Efficacy for Exercise (SEE) Scale

    The Self-Efficacy for Exercise (SEE) scale is a questionnaire designed to measure an individual's confidence in their ability to exercise regularly. Participants rate their confidence on a scale, often from 0 (not at all confident) to 10 (very confident).

    Measured: Baseline and post-intervention (approximately 8 weeks)

  14. Short Acculturation Scale for Hispanics (SASH)

    The Short Acculturation Scale for Hispanics is a 12-item questionnaire developed to measure the degree of acculturation experienced by Hispanics in the United States. Scores range from 1 to 5, where higher scores indicate a greater level of acculturation to mainstream U.S. culture.

    Measured: Baseline

  15. Discrimination in Medical Settings Scale

    The Discrimination in Medical Settings (DMS) scale is a 7-item questionnaire that measures patient-reported experiences of mistreatment in healthcare settings. It uses a 5-point Likert scale for each item, asking patients how often they have experienced specific scenarios, such as being treated with less courtesy or feeling a doctor is not listening to them. Higher scores on the scale indicate more frequent experiences of discrimination, and it is used to study disparities in healthcare.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  16. Brief Pain Inventory (BPI)

    The Brief Pain Inventory (BPI) is a 9-item self-report tool that measures pain severity and how pain interferes with daily activities on a 0-10 scale, with higher scores indicating greater pain. It shows excellent reliability, with Cronbach's alpha typically between 0.80 and 0.95.

    Measured: Baseline and post-intervention (approximately 8 weeks)

  17. Leisure Time Exercise Questionnaire of Godin and Shephard

    The Leisure-Time Exercise Questionnaire (LTEQ) by Godin and Shephard is a brief self-report measure that asks about the frequency of mild, moderate, and strenuous exercise during a typical week. Responses are converted into a weekly leisure activity score by weighting each intensity level. The LTEQ demonstrates good reliability, with Cronbach's alpha values around 0.80 and strong test-retest stability.

    Measured: Baseline and post-intervention (approximately 8 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start1 Apr 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06844981
Sponsor's protocol ID
Pro2025000098
Status last verified
Aug 2026
First submitted
28 Jan 2025
Last updated
7 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Latin Dance in people with Cancer Survivorship and Sleep Disturbances, run by Rutgers, The State University of New Jersey at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Evelyn Arana, DrPH (908-642-0861, earana@CINJ.Rutgers.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the Intervention (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in